Beruflich Dokumente
Kultur Dokumente
From GMOs to Nanotechnology and beyond; learning from the past, looking to the future
Andrew Moore, Science & Society Programme Manager, European Molecular Biology Organization
EMBO
GMO debate
Consumer information: You can easily recognise genetically modified foods by their evil smile; crops without genes just look stupid.
Society wants, needs and appreciates marvelous things, but is it prepared to accept the way in which they are made, and their possible risks?
Nanotechnology
Picture sources: Fruit and veg. basket: EMBO reports, 5, 5, (2004); immune cell: Kompetenzzentrum fr Nanolanalytik, Munich, Germany; biomolecular motor: Cornell University, USA
EMBO
EMBO
EMBO
EMBO
Part 2: the culturing of public opinion - or the effect of NGOs and the media
EMBO
EMBO
EMBO
EMBO
EMBO
EMBO
EMBO
EMBO
Frankenstein tomato?
www.veggies.co.uk
EMBO
EMBO
EMBO
Headlines on nanotechnology
EMBO
EMBO
EMBO
THIS astonishingly beautiful flower is less than one THOUSANDTH the width of a human hair
EMBO
EMBO
EMBO
EMBO
RS / RAE definitions "Nanoscience is the study of phenomena and manipulation of materials at atomic, molecular and macromolecular scales, where properties differ significantly from those at a larger scale." "Nanotechnology is the design, characterisation, production and application of structures, devices and systems by controlling shape and size at nanometre scale."
EMBO
EMBO
EMBO
GM - is it safe?
No evidence of adverse effects on consumers Extensive farm scale evaluations (2003) Report from ACRE (2004) Review of science behind GM (2004) Several reports on scientific, social and ethical issues Nuffield Council paper on use of GM in dev. World BMA states No robust evidence to prove that GM foods are unsafe. (2004) New EU regulations on labelling and traceability None of the above had any noticeable effect.
EMBO
Nanotech - is it safe?
RS evidence on environmental applications and impacts (2003) RS / RAE study (July 2004) Many nanotechnologies pose no new risks to health A substance needs new safety testing once in nanoparticulate form Life cycle assessments needed No case for a moratorium EU funded project Nanosafe (FP6) in progress How will the precautionary principle be applied if and when needed?
EMBO
Part 5: Europe and the rest of the world - or our involvement in the
bigger picture
EMBO
EMBO
EMBO
EMBO
EMBO
EMBO
EMBO
Nanotechnology has generally not yet reached the state of application that elicit intense public interest. Nanotechnology is a big investment; there is a lot at stake. Public fears exist concerning self replicating systems; regulators concerned about particles etc. Nanobiotechnology can easily fall into the pre-made trap of GM. Nanobiotechnology will likely give us the first nanobiologically active entities for use in the human body. Bio-nanomachines have already been made by nature, and their adaptation for use by or in humans is on the horizon.
EMBO
Possible problems with public perception of nanobiotechnology could easily spread to whole field (interdisciplinarity). A very large part of the science of the future will likely depend on nano-technological approaches. Perhaps scientists and industry should concentrate on talking in terms of applications rather than nano-x or y. If somethingunconsented outrages or a report scares, the GM saga could be repeated with nanotechnology (human or environmental risk). Many unknowns, prospects that seem fantastic today
EMBO
EMBO
Public outrage is a very powerful component of risk perception - scientists (and industry) heed! Outrage at one sector of a field can spread like wildfire > indiscriminate demonisation. Once public perception badly damaged, no number of studies can get discussions back onto a balanced track. Unilateral moratoria not as good as remaining in the game, however slowly you move. Misconceptions about lack of regulation of R&D must not be allowed to develop - scientists communicate! Science is not out of control.
EMBO
Scientists should: be more proactive rather than reactive; co-ordinate and support each other; master the art of rapid media communication; master the art of risk communication. Early risk identification and analysis Consultation by industry; not post hoc convincing Absolute clarity, accuracy and transparency; resisting temptation to use nano trivially as a marketing aid. Public fears or possible areas of anxiety must be discussed, however irrational they may seem, or however far from emergence the technology in question is. Introduction of latest science and debate in classroom.
EMBO
EMBO